Keyphrases
Amyotrophic Lateral Sclerosis
100%
Superoxide Dismutase 1 (SOD1)
30%
Antisense Oligonucleotides
28%
Neurodegenerative Diseases
14%
TAR DNA-binding Protein 43 (TDP-43)
13%
C9orf72
12%
Central Nervous System
12%
Motor Neuron
11%
Frontotemporal Dementia
10%
Cerebrospinal Fluid
8%
Clinical Trials
8%
Placebo
7%
Duchenne muscular Dystrophy
7%
Spinal Cord
7%
Motor Neuron Disease
6%
Tauopathy
6%
Becker muscular Dystrophy
6%
Alzheimer's Disease
6%
MicroRNA
5%
Reldesemtiv
5%
Antisense Oligonucleotide Therapy
5%
Mitochondria
5%
Disease Progression
5%
Age of Onset
5%
Mouse Model
5%
Neuroscience
Amyotrophic Lateral Sclerosis
72%
Antisense Oligonucleotide
21%
Neurodegenerative Disorder
14%
Copper Zinc Superoxide Dismutase
12%
Frontotemporal Dementia
10%
Central Nervous System
10%
SOD1
8%
MicroRNA
7%
Tauopathy
7%
Alzheimer's Disease
7%
Messenger RNA
5%
Motor Neuron Disease
5%
Astrocyte
5%
Muscle Disorder
5%
Biochemistry, Genetics and Molecular Biology
Antisense
14%
Superoxide Dismutase
13%
SOD1
13%
Tau
12%
Liquid
11%
Oligonucleotide
11%
Motor Neuron
10%
Transactive Response Dna Binding Protein-43
8%
RNA
7%
Mitochondrion
6%
Clinical Trial
5%
C9orf72
5%
Pharmacodynamics
5%